Microsoft and Anthropic Explore AI Chip Collaboration Following 5 Billion Investment Indias Gen Z Protests and Website Shutdown Highlight Rising Political Risk for Investors Kevin Warsh Sworn In as Fed Chair Promises ReformOriented Approach in White House Ceremony Commonwealth Bank CEO Highlights AIs Impact on Team Size Urges Workforce Planning European Markets Reach OneMonth High on Tech Sector Strength and Geopolitical Optimism Google Employee Charged with 1M Polymarket Insider Trading Bet on Search Term NEN Q4 2024 Earnings Strong PerUnit Earnings Highlight Steady Real Estate Performance SHOO Q1 2026 Earnings EPS Surges Past Estimates by 1433 ClearOne Inc CLRO Q2 2018 Earnings EPS Surprise Drives Stock Gain Amid Revenue Silence MCHP Q1 2026 Earnings EPS Beat Fails to Lift Stock as Revenue Concerns Linger KURA Q1 2026 Earnings ClinicalStage Biotech Misses Wall Street Estimates Stock Slides FGN Q1 2026 Earnings EPS Misses Analyst Estimates Amid Market Volatility Prothena PRTA Edges Higher Amid Biotech Sector Volatility Erie Indemnity ERIE Shows Modest Decline as Price Consolidates Near Key Support Enovis Corporation ENOV Holds Near Support Amid Modest Decline Lionheart Holdings Unit CUBWU Holds Steady at 1085 as Market Awaits Catalyst Republic Digital Acquisition Company Unit RDAGU Holds Steady Near 1055 Amid Low Volatility Dow SP 500 Nasdaq Futures Dip as USIran Negotiations Create Uncertainty Camden National Corporation CAC Q1 2026 Earnings Slight EPS Beat Amid Stable Performance Enerpac Tool Group EPAC Holds Steady Near 3458 as Consolidation Continues VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion AMTD Q4 2020 Earnings EPS Surges Past Estimates Amid Strong Performance CICC Q1 2026 Earnings EPS Misses Estimates Notes Decline LBRDK Q3 2025 Earnings EPS Surges Past Estimates Stock Reacts Modestly CHRW Q1 2026 Earnings EPS Surpasses Estimates by 681 Stock Declines Dow Q1 2026 Earnings EPS Surprises to the Upside Amid Challenging Conditions ELTX Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline